Close Menu

BARCELONA – Researchers from the Zhejiang Cancer Hospital in Hangzhou, China have found what they believe could be a DNA methylation signature predictive of central nervous system metastases in patients with advanced non-small cell lung cancer (NSCLC).

In a presentation at the annual meeting of the European Society for Medical Oncology in Barcelona on Friday, Zheijang researcher Yanjun Xu reported her group's work in analyzing DNA mutations and methylation to find possible biomarkers of lung cancer metastasis to the brain or the leptomeninges.

To read the full story....

...and receive Weekly News bulletins.

Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.

Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.


This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 


This webinar will tell the story of Versiti’s journey in transforming genetic testing from a manual to a digitized process. It will include detail on how the organization succeeded, pain points along the way, a novel approach to variant assessment, and future plans for the program.


This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.